NEWS   I   CONTACT      

Board of Directors

Board of Directors

nicole-formica-schiller-main

Nicole Formica-Schiller

CEO, Founder

“Pamanicor Health AG is the realization of my goals of building an international company based on expertise, values and excellence. It provides me the platform to help simplify the complexity of bioethics and digital health in the innovation of new therapies to advance health and wellbeing of all healthcare stakeholders. To ensure high quality patient-centric and ethical healthcare solutions as well as drug development it is essential that we are at the forefront of the latest developments and open up the dialogue with all relevant stakeholders.” 

  • Established expert in the area of AI, Blockchain, Big Data and Bioethics in healthcare innovation and drug development, External and Governmental Affairs, EU and International decision-making, Health Policy, Reforms and Regulations as well as high-level Stakeholder Relations Management
  • Invited by the Data Ethics Commission of the German Government in 2019 to share her views at the roundtable-discussion “For an ethical creation of our digital future”.
  • Selected by Forbes in 2019 amongst other leaders with the best/most exciting/innovative ideas, to attend “Writing Future Codes” Summit in Zurich sharing her approach on the implications of AI in Life Sciences and Biopharmaceuticals
  • Initiator of project study “Blockchain and AI: A new paradigm shift in biopharmaceutical financing and R&D” at the Center for Entrepreneurial and Financial Studies (Prof. Ann-Kristin Achleitner etc.) of the Technical University Munich (TUM)
  • Vice-President and Board Member of Healthcare Businesswomen’s Association (HBA) Zurich chapter, the world biggest nonprofit association for gender diversity in the healthcare industry
  • 15+ years international professional experience in more than 10 cities worldwide (Munich, London, Frankfurt/Main, Kuala Lumpur, Hong Kong, Moscow, Zurich etc.), e.g. as Task Force member and Liaison Officer of the CEO of one of Europe’s biggest infrastructure projects, Allianz AG, Munich RE, Freshfields Bruckhaus Deringer and Shearman Sterling
  • Attorney-at-Law (1st and 2nd Legal State Examination Germany) with additional university business degree
mel-formica

Mel Formica, PhD, MBA

Member of the Board and Chief Scientific and Health Policy Advisor

“Pamanicor Health AG, enables me to not only advise our international clients on their business challenges. It also provides me with the opportunity to help them understand the fast-changing Life Sciences and Biopharmaceuticals world including new advanced therapies and therefore, partner with them to create sustainable business transformations that benefit patients all over the globe.”

  • 20+ years of experience in leadership roles spanning clinical research, marketing, strategic consulting and value and evidence generation
  • Successful global blockbuster biopharmaceutical product launches
  • International expert in integrating novel evidence-based methods to drive efficiencies in medical and commercial data generation, data synthesis and data utilization
  • Transformation leader who has pioneered new organizational models leading to improved operating efficiency and driving business growth
  • Leadership roles at major biopharmaceutical companies including Takeda Pharmaceuticals International, Amgen Inc., Abbott Laboratories working in Australia, U.S., China, Japan, Switzerland and Europe
  • Academic and research appointments as Assistant Professor at the College of Physicians and Surgeons of Columbia University, New York, St. Luke’s-Roosevelt Hospital Center, New York and Helen Hayes Hospital, New York